上方与鼻侧/颞侧激光周边虹膜切开术后新发视觉障碍的比较:一项前瞻性随机试验
这项多中心随机前瞻性单盲试验纳入559例南印度双眼原发性房角关闭可疑、原发性房角关闭或原发性房角关闭青光眼患者,随机接受双眼上方或鼻侧/颞侧激光周边虹膜切开术。术后2周问卷评估显示,上方组与鼻侧/颞侧组新发一项或以上视觉障碍症状的比例分别为8.4%与9.5%(P=0.7),无显著差异;多因素logistic回归中切开位置、面积及总激光能量均未预测新发视觉障碍。结论认为激光周边虹膜切开术就视觉障碍而言可能是安全的,与位置、面积及激光能量无关。
要点
- 上方组与鼻侧/颞侧组术后新发≥1项视觉障碍症状比例分别为8.4%与9.5%(P=0.7),无显著差异。
- 术后最常见新发症状为线性视觉障碍2.7%、眩光4.3%、视物模糊4.3%。
- 多因素分析中切开位置、面积及总激光能量均未预测新发视觉障碍(P均>0.1)。
核心结论
- 激光周边虹膜切开术就视觉障碍而言可能是安全的,与切开位置、面积及所用激光能量无关。
研究设计与样本
- 多中心、随机、前瞻性、单盲试验,纳入559例30岁及以上南印度双眼原发性房角关闭可疑、原发性房角关闭或原发性房角关闭青光眼患者。
- 患者随机接受双眼上方或双眼鼻侧/颞侧激光周边虹膜切开术,术前及术后2周采用基于Spaeth等描述的7项视觉障碍症状问卷评估。
主要发现
- 上方组(n=285)与鼻侧/颞侧组(n=274)在年龄(P=0.6)、性别(P=0.7)及疾病分布(P=0.7)方面匹配。
- 两组初始激光能量设置相似(P=0.3),但上方组所需击射次数更多(P=0.006)且总能量更高(P<0.001)。
- 术后前房反应(P=0.7)及激光周边虹膜切开面积(P=0.9)两组无显著差异。
- 术前≥1项视觉障碍症状比例上方组15.8% vs 鼻侧/颞侧组13.9%(P=0.1),任一单项症状两组P均>0.2。
- 术后全部患者中8.9%报告≥1项新发症状,最常见为线性视觉障碍2.7%、眩光4.3%、视物模糊4.3%。
关键数值与推荐
- 上方组与鼻侧/颞侧组新发≥1项视觉障碍症状比例分别为8.4%与9.5%(P=0.7)。
- 任一新发单项症状频率两组差异无统计学意义(P均≥0.3)。
- 多因素logistic回归中切开位置、切开面积及总激光能量均未预测术后新发视觉障碍的更高比值比(P均>0.1)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine whether laser peripheral iridotomy (LPI) location affects postoperative dysphotopsia symptoms. DESIGN: Multicenter, randomized, prospective, single-masked trial. PARTICIPANTS: Five hundred fifty-nine South Indian patients 30 years of age or older diagnosed as primary angle-closure suspects (PACSs) or with primary angle closure (PAC) or primary angle-closure glaucoma (PACG) in both eyes. METHODS: Patients were randomized to either bilateral superior or bilateral nasal/temporal LPI. Occurrence of new visual disturbances was evaluated before and 2 weeks after LPI using a questionnaire based on the 7-item dysphotopsia symptoms described by Spaeth et al. MAIN OUTCOME MEASURES: New-onset dysphotopsia symptoms. RESULTS: Superior LPI (n = 285) and nasal/temporal LPI (n = 274) patients were matched for age (P = 0.6), gender (P = 0.7), and distribution of PACS versus PAC or PACG (P = 0.7). Similar initial laser energy settings were used in both groups (P = 0.3), although superior LPIs required more shots (P = 0.006) and greater total energy (P < 0.001) than nasal/temporal LPIs. No significant differences in postoperative anterior chamber reaction (P = 0.7) or LPI area (P = 0.9) were noted between the 2 groups. No group differences were noted regarding the proportion of patients demonstrating 1 or more dysphotopsia symptoms before LPI (15.8% for superior vs. 13.9% for nasal/temporal; P = 0.1) or any individual dysphotopsia symptom (P > 0.2 for all). After LPI, 8.9% of all patients reported 1 or more new symptoms, the most common consisting of linear dysphotopsias, glare, and blurring in 2.7%, 4.3%, and 4.3% of patients, respectively. Patients undergoing superior LPI were not more likely to describe the new onset of 1 or more dysphotopsia symptoms as compared with patients undergoing nasal/temporal LPI (8.4% vs. 9.5%; P = 0.7), nor did the frequency of any new individual symptoms differ by group (P ≥ 0.3 for all). In multivariate logistic regression analysis, neither LPI location nor LPI area nor total laser energy predicted higher odds of new postoperative dysphotopsias (P > 0.1 for all). CONCLUSIONS: Laser peripheral iridotomy likely is safe with respect to visual dysphotopsias regardless of location, LPI size, and amount of laser energy used.
引用
- Srinivasan K, Zebardast N, Krishnamurthy P, et al. Comparison of New Visual Disturbances after Superior versus Nasal/Temporal Laser Peripheral Iridotomy: A Prospective Randomized Trial. Ophthalmology. 2017. PMID: 29096997. doi:10.1016/j.ophtha.2017.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。